Happy to share our recent publication in Frontiers in Oncology - examining the relationship of pre-transplant chemotherapy cycles to transplant outcomes in pediatric AML in CR1
https://t.co/qazYUjmq69
Happy to share our recent review of late and long term health outcomes in patients with Fanconi Anemia - better transplant leads to longer life and unique complications.
https://t.co/vYRAN0MOkQ
#TrendingWithImpact: On April 25, 2024, researcher Alex Hoover from @umnmedschool@UMNews published a new editorial in Oncoscience, entitled, “The price of hope: CAR-T therapy in pediatric leukemia”
DOI: https://t.co/avw0XIydln
Understanding the true cost of the therapies we prescribe is a crucial component in being able to advocate for our patients and provide widespread and equitable access!
https://t.co/aHn0pSDHYm
Sharing our recently accepted publication “Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL”
Enjoy!
https://t.co/PLBl1wmpJO
Cancer-fighting heroes from our children’s hospital took to the court during halftime at Tuesday’s @GopherMBB game for an annual “Coaches vs. Cancer” game. This initiative is led by @AmericanCancer and the National Association of Basketball Coaches. 🏀
Four-year-old cancer warrior Bailey is taking on her journey with a fighting spirit. During the @KS95forKids Radiothon on Dec. 8, you can support kids like Bailey and patients @GilletteChildrn to help support their futures. Find out how you can help. ➡️ https://t.co/GIOpFkcckr
This is why observational studies of diet in cancer aren’t reliable.
They reliably fail to be reproduced in randomized trials.
Eat healthy. Live well. But don’t expect it to shrink your cancer.
A huge thank you to Vikings player Alexander Mattison for making our patients smile today! Mattison autographed footballs and answered our patients’ burning questions about his experience as a professional athlete. Check out some of our favorite moments! 🏈
First locally manufactured CD19 CAR-T approved in India 🇮🇳 NexCAR19 (Actalycabtagene autoleucel) now let’s wait for that pricing to put all other commercial 🚗 to shame… #CARTcells
The incidence of severe acute/chronic graft-versus-host disease is <6% in matched donor myeloablative conditioned hematopoietic cell transplantation with post-transplantation cyclophosphamide/tacrolimus/mycophenolate mofetil. Read more: https://t.co/pU9Lx4Y22k #HSCT#GVHD
I constantly remind myself as a doctor — as an oncologist especially?! — that the current patient has no idea what’s going on with the last patient or the next patient, NOR SHOULD THEY
Every encounter I have to recalibrate my demeanor to “meet triumph and disaster just the same”
Here, some of the world’s leading medical experts just happen to come with the most caring hearts. We’re honored to be recognized in 2023 as the top-ranked children’s hospital in the Twin Cities, according to the @usnews. Learn more. ➡️ https://t.co/R4pGj0U8sH
Something I didn't expect to see during my career:
Severe acute and chronic #GVHD <6% in well-matched myeloablative transplantation.
One death due to GVHD out of 125 patients, and that was too many.
It's undeniably a new era in #BMT.
https://t.co/17AwCMXhmu
$100,000! This incredible donation from #cancersurvivor Megan Wagner of Reading 4 Research will support break-through treatments and research for patients at our hospital battling cancer. Thank you for helping us provide life-changing care to our patients and families! ♥️